Detection and quantitation of binding and dissociation of biomolocules are critical in the study of disease pathways, in the screening for and development of potential drugs, and in post-clinical patient monitoring.

On Silicon Kinetics 3D label-free biosensor platform, no reporter element or tag (such as a fluorescent label) is required to detect and quantitate the binding of biomolecules to analytes in a sample.

As the most economical and versatile platform in the industry, Silicon Kinetics brings biomolecular interaction analysis within the reach of the individual researcher, whether in academia or in various research, drug discovery, development or patient monitoring departments of biotech and pharmaceutical firms.